BTA 0.00% 57.0¢ biota holdings limited

refresh your memory from gsk website, page-6

  1. 1,833 Posts.
    lightbulb Created with Sketch. 7
    "This new capacity has been achieved by increasing production levels of Relenza Diskhaler from 60 million treatment courses to 90 million and building new capacity to produce 100 million treatment courses a year of Relenza Rotacaps. This alternative Relenza treatment was granted temporary approval by Swedish regulators earlier this month..."

    It's there in black and white. They are producing 100 million Rotacaps p/a and HAVE THE APPROVAL TO SELL THEM! Why people keep dismissing this little fact is beyond me. Do you expect to be told each time a Rotacap is sold?
 
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.